TG/HDL Ratio

Blood

Lipid Panel

The TG/HDL ratio is your triglyceride level divided by your HDL cholesterol, a simple calculation from a standard lipid panel. It serves as a practical surrogate for insulin resistance and for a predominance of small, dense LDL particles. A preventive practice uses it as an accessible window into metabolic health beyond individual lipid numbers.

What It Measures

Triglycerides divided by HDL; surrogate for insulin resistance and small dense LDL

Optimal vs. Lab Range

Longevity Optimal

<1.0 ideal; <2.0 acceptable

Target range for optimal health and longevity based on research.

Standard Lab

N/A (calculated)

Population-based reference range from standard labs.

Why It Matters

A high ratio is associated with insulin resistance, metabolic syndrome, a shift toward small dense LDL, and elevated cardiovascular risk, often surfacing metabolic dysfunction before other markers move. Because it links lipid data to glucose metabolism, it complements fasting insulin and HOMA-IR in painting a fuller metabolic picture. A low ratio is generally favorable and suggests better insulin sensitivity and a healthier LDL particle pattern. For longevity, this inexpensive calculation offers an early, actionable read on metabolic trajectory.

When Low

Generally favorable when low

When High

Insulin resistance, metabolic syndrome, small dense LDL predominance, cardiovascular risk

How to Optimize

Because the ratio tracks metabolic health, the most effective steps lower triglycerides and support HDL: reducing refined carbohydrates, incorporating structured fasting where appropriate, exercising regularly, and adding omega-3 fatty acids. Improving insulin sensitivity through weight management and activity tends to move both components favorably at once. Progress is best gauged by rechecking the underlying triglyceride and HDL values over time. Targets and treatment are individualized with your physician; this content is educational and not a substitute for medical advice.

Key Interventions & Linked Compounds

Moderate evidence

Key Interventions

Carb restriction

exercise

omega-3

fasting

Linked Compounds & Supplements

Omega-3

Berberine

Chromium

Curated from clinical literature. Individual results vary; consult a qualified clinician before changing a protocol.

Ordering Notes

Specimen

Serum or plasma (venous draw)

Patient prep

No fasting required. Maintain usual diet and medications unless advised.

Recommended cadence

Quarterly

Reporting unit

Confirm with the performing lab — units vary by region.

Pre-analytic notes

Standardize draw time of day, hydration, and recent exercise. Note any acute illness, supplements, or hormonal therapies on the requisition.

Recommended Follow-Up Actions

1
Confirm the result is reliable
Repeat abnormal values before acting — preferably from the same lab, same time of day, and under consistent prep. Rule out acute illness, recent intense exercise, or medication effects that can shift TG/HDL Ratio.
2
Compare against optimal, not just lab range
Use the optimal window above as the target. Lab "normal" is built from the general population and often misses early dysfunction.
3
Pair with related markers
Order a complementary panel covering metabolic, inflammatory, and hormonal context to interpret this marker properly.
4
Discuss interventions with a clinician
Use the interpretation guidance above to frame the conversation. Bring trends, not just one datapoint, to your visit.
5
Re-test on a defined cadence
If a change is implemented, re-measure in 8–12 weeks for fast-moving markers, or 3–6 months for slower ones, to confirm response before escalating.